Sever Pharma
Sever Pharma, officially known as Sever Pharma Solutions, is a leading player in the pharmaceutical industry, headquartered in Sweden (SE). Founded in 2010, the company has established a strong presence in Europe and North America, specialising in contract development and manufacturing services for the pharmaceutical and biotechnology sectors. Sever Pharma is renowned for its innovative approach to drug formulation and production, offering a range of services that include analytical development, clinical trial material manufacturing, and commercial supply. Their commitment to quality and efficiency has positioned them as a trusted partner for clients seeking reliable solutions in drug development. With a focus on advancing healthcare, Sever Pharma has achieved significant milestones, including successful collaborations with major pharmaceutical companies, solidifying its reputation as a key player in the market.
DitchCarbon Score
How does Sever Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sever Pharma's score of 19 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sever Pharma's reported carbon emissions
In 2023, Sever Pharma reported total carbon emissions of approximately 555,790 kg CO2e. This figure includes 37,550 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources. Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling, accounted for about 244,010 kg CO2e. The most significant portion of their emissions came from Scope 3, totalling approximately 274,230 kg CO2e, which includes categories such as employee commuting (145,610 kg CO2e) and waste generated in operations (11,961 kg CO2e). Currently, Sever Pharma has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of formal commitments suggests that while the company is aware of its carbon footprint, it may need to establish clearer strategies for emissions reduction in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 37,550 |
| Scope 2 | 244,010 |
| Scope 3 | 274,230 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sever Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
